Biocompatibility, tunable porosity, reversible self-healing, localized and sustained cytokine release (CXCL13, LIGHT), promoted TLSs formation, antigen-specific T-cell activation, tumor growth inhibition, tumor immunotherapy. The gene discussed is TNFSF14; the disease is neoplasm.